{"changes":[],"country":"US","description":"Emmyon develops biopharmaceuticals targeting age-related muscle decline (sarcopenia) and cancer-related cachexia. It serves geriatric patients and oncology patients losing muscle mass and function. Its small-molecule muscle-anabolic mechanism is a pathway that GLP-1 and existing oncology drugs leave untreated.","domain":"emmyon.com","employees":null,"founded":2013,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":43.157285,"lng":-77.615214,"location":"Rochester, USA","name":"Emmyon, INC.","rounds":[{"amountQuarantined":false,"amountUsd":1990000,"currency":"USD","date":"2025-01-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-02","status":"attributed","url":null},"status":"attributed","type":"strategic","url":null}],"slug":"emmyon-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-02","status":"attributed","url":null},{"fact":"existence","publisher":"emmyon.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://emmyon.com"},{"fact":"description","publisher":"emmyon.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://emmyon.com"}],"stage":"series-b+","techStack":["Google Analytics","Google Tag Manager","Sucuri","jQuery Migrate 3.4.1","DoubleClick Floodlight","OWL Carousel","WordPress","Bluehost","PHP","MySQL","jquery 3.7.1"],"totalRaisedUsd":3009375,"updatedAt":"2026-05-02"}